ribavirin has been researched along with Thyroid Diseases in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.03) | 18.2507 |
| 2000's | 18 (54.55) | 29.6817 |
| 2010's | 14 (42.42) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attarian, S; Haigentz, M; Kaubisch, A; Sharma, J; Zonszein, J | 1 |
| Berendt-Obołończyk, M; Bianek-Bodzak, A; Lakomy, A; Lewczuk, A; Michalska, Z; Moszkowska, G; Obołończyk, Ł; Radowska, D; Siekierska-Hellmann, M; Sworczak, K; Wiśniewski, P | 1 |
| Chang, YK; Chen, KH; Chen, KT; Tseng, YT | 1 |
| Bukatman, R; Gordon, P; Kramer, D; Krug, P; Mermelstein, P | 1 |
| Cao, YG; Hou, HR; Jin, X; Kang, Y; Liang, SQ; Liu, JP; Shang, J | 1 |
| Ianna, EA; Jones, TL; Reeves, GE; Tran, HA | 2 |
| Huo, N; Li, MR; Shao, CP; Xi, HL; Xu, XY; Yu, M; Zhang, RW | 1 |
| Choe, WH; Hwang, Y; Kim, JH; Kim, W; Kwon, SY; Yu, HM | 1 |
| Abdul-Kareem, S; Eid, Y; El-Sayed, M; Hamza, I; Marzaban, R | 1 |
| Obołończyk, L; Siekierska-Hellmann, M; Sworczak, K | 1 |
| Baloch, GH; Ghori, R; Jaffri, M; Masood, N; Memon, A; Memon, I; Memon, KI; Memon, S | 1 |
| Burke, V; Cheng, W; Connelly, C; Flexman, J; Jamil, KM; Kontorinis, N; Leedman, PJ; McInerney, M; Metcalf, C; Nazareth, S; Tarquinio, L | 1 |
| Bojunga, J; Friedrich-Rust, M; Theobald, J; Zeuzem, S | 1 |
| Aslam, M; Hussain, T; Khan, DA; Khan, SA; Nadeem, A | 1 |
| Elefsiniotis, I; Konstantinou, E; Mihas, C; Saroglou, G; Vezali, E | 1 |
| Chan, HL; Cheng, AY; Wong, VW | 1 |
| Attia, JR; Gibson, R; Malcolm Reeves, GE; Tran, HA | 1 |
| Costelloe, SJ; Dusheiko, G; Jacobs, M; Morris, C; Schulz, J; Thomas, M; Vaghijiani, T; Vanderpump, MP; Wassef, N; Whiting, S | 1 |
| Gołabek, V; Kupś-Rzepecka, J; Woźniakowska-Gesicka, T | 1 |
| Anagnostis, P; Aristidis, D; Aristidis, S; Deliyiannidis, A; Eleni, OK; Eugenidis, N; Georgios, N; Grammatikos, N; Kaliopi, P; Kargiotis, K; Konstantinos, K; Konstantinos, S; Nalmpantidis, G; Nikolaos, E; Nikolaos, G; Orfanou-Koumerkeridou, E; Panagiotis, A; Patsiaoura, K; Slavakis, A; Soufleris, K; Themistoklis, V; Vasiliadis, T | 1 |
| Chen, XY; Guo, DD; Huang, YX; Ma, LN; Ren, S; Yin, JM; Zheng, YH | 1 |
| Duclos-Vallée, JC | 1 |
| Carbone, A; Carella, C; Cioffi, M; Mazziotti, G; Morisco, F; Sorvillo, F | 1 |
| Fried, MW; Russo, MW | 1 |
| Matsumori, A | 1 |
| Bini, EJ; Mehandru, S | 1 |
| Changchien, CS; Kee, KM; Lee, CM; Lu, SN; Tung, HD; Wang, JH; Wang, PW | 1 |
| Asnis, GM; De La Garza, R | 1 |
| Chang, WY; Chen, SC; Chuang, WL; Dai, CY; Hsieh, MY; Huang, JF; Lee, LP; Lee, PL; Lin, ZY; Wang, LY; Yu, ML | 1 |
| Attia, JR; Batey, RG; Jones, TL; Tran, HA | 1 |
| Chu, PL; Chung, GB; Liu, CH; Wu, KD; Yang, WS | 1 |
| Clarke, G; Crowe, J; Fielding, JF; Sachithanandan, S | 1 |
7 review(s) available for ribavirin and Thyroid Diseases
| Article | Year |
|---|---|
[Side effects during interferon-alpha therapy of hepatitis C with special consideration of thyroid dysfunction].
Topics: Antiviral Agents; Hepatitis C; Humans; Interferon-alpha; Ribavirin; Risk Factors; Thyroid Diseases; Thyroiditis | 2007 |
Development of thyroid diseases in the treatment of chronic hepatitis C with alpha-interferon may be a good prognosticator in achieving a sustained virological response: a meta-analysis.
Topics: Adult; Antiviral Agents; Clinical Audit; Drug Therapy, Combination; Evidence-Based Medicine; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Odds Ratio; Prospective Studies; Ribavirin; Risk Assessment; RNA, Viral; Thyroid Diseases; Time Factors; Treatment Outcome; Viral Load | 2009 |
[Treatment of hepatitis C virus associated extrahepatic manifestations].
Topics: Antiviral Agents; Autoantibodies; Clinical Enzyme Tests; Clinical Trials as Topic; Cryoglobulinemia; Drug Therapy, Combination; Glomerulonephritis, Membranoproliferative; Hepatitis C; Humans; Interferons; Lichen Planus; Lymphoma, Non-Hodgkin; Porphyria Cutanea Tarda; Prospective Studies; Purpura, Thrombocytopenic; Retrospective Studies; Ribavirin; Sjogren's Syndrome; Thyroid Diseases; Time Factors; Transaminases | 2002 |
Side effects of therapy for chronic hepatitis C.
Topics: Antiviral Agents; Drug Therapy, Combination; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lung Diseases; Mental Disorders; Nervous System Diseases; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thyroid Diseases | 2003 |
[Effect of IFN treatment for extrahepatic manifestations].
Topics: Antiviral Agents; Cardiomyopathies; Cryoglobulinemia; Drug Therapy, Combination; Female; Glomerulonephritis, Membranoproliferative; Hepatitis C; Humans; Interferon-alpha; Interferon-beta; Middle Aged; Myositis; Ribavirin; Thyroid Diseases; Treatment Outcome | 2004 |
Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches.
Topics: Anemia; Antiviral Agents; Depressive Disorder, Major; Hepatitis C, Chronic; Humans; Intercellular Adhesion Molecule-1; Interferon alpha-2; Interferon Type I; Interferon-alpha; Nitric Oxide; Paroxetine; Peptide Hydrolases; Polyethylene Glycols; Prevalence; Recombinant Proteins; Ribavirin; Risk Factors; Selective Serotonin Reuptake Inhibitors; Thyroid Diseases | 2006 |
Pegylated interferon-alpha2beta in combination with ribavirin does not aggravate thyroid dysfunction in comparison to regular interferon-alpha2beta in a hepatitis C population: meta-analysis.
Topics: Adult; Drug Combinations; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thyroid Diseases | 2007 |
1 trial(s) available for ribavirin and Thyroid Diseases
| Article | Year |
|---|---|
[Thyroid dysfunctions in children with chronic hepatitis C during interferon alpha-2b therapy].
Topics: Adolescent; Antiviral Agents; Causality; Child; Child, Preschool; Comorbidity; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thyroid Diseases | 2011 |
25 other study(ies) available for ribavirin and Thyroid Diseases
| Article | Year |
|---|---|
Multiple Endocrine and Neoplastic Diseases After Unsuccessful Treatment of Hepatitis C With Interferon and Ribavirin.
Topics: Carcinoma, Hepatocellular; Diabetes Mellitus, Type 1; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Male; Middle Aged; Polyendocrinopathies, Autoimmune; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thyroid Diseases | 2017 |
Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study.
Topics: Adult; Antiviral Agents; Autoantibodies; Female; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Prognosis; Prospective Studies; Ribavirin; Risk Factors; Thyroid Diseases; Thyroid Gland; Young Adult | 2017 |
Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Case-Control Studies; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prognosis; Recombinant Proteins; Ribavirin; Risk Factors; Taiwan; Thyroid Diseases; Young Adult | 2019 |
Energy dialogue technique in healing and health: relieving side effects and thyroid dysfunction in a male with hemophilia receiving pegylated interferon and ribavirin treatment for hepatitis C virus--an anecdotal case study.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Mind-Body Relations, Metaphysical; Ribavirin; Thyroid Diseases; Thyroid Gland | 2013 |
[Clinical features of antiviral therapy-induced thyroid disease in patients with chronic hepatitis C].
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Polyethylene Glycols; Ribavirin; Thyroid Diseases | 2013 |
THE ABSENCE OF THYROID DISEASE IN AN AUSTRALIAN HEPATITIS C COHORT TREATED WITH TRIPLE COMBINATION THERAPY: A PARADIGM SHIFT.
Topics: Adult; Australia; Case-Control Studies; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Proline; Protease Inhibitors; Retrospective Studies; Ribavirin; Thyroid Diseases | 2015 |
Thyroid dysfunction in Chinese hepatitis C patients: Prevalence and correlation with TPOAb and CXCL10.
Topics: Adult; Antiviral Agents; Asian People; Autoantibodies; Autoantigens; Biomarkers; Chemokine CXCL10; China; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Iodide Peroxidase; Iron-Binding Proteins; Male; Middle Aged; Polyethylene Glycols; Prevalence; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Sex Factors; Thyroid Diseases; Thyroid Gland; Time Factors; Treatment Outcome | 2015 |
Incidence of and risk factors for thyroid dysfunction during peginterferon α and ribavirin treatment in patients with chronic hepatitis C.
Topics: Adult; Aged; Antiviral Agents; Autoantibodies; Biomarkers; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Republic of Korea; Retrospective Studies; Ribavirin; Thyroid Diseases; Thyroid Gland; Time Factors; Treatment Outcome | 2015 |
Thyroid Dysfunction in Chronic Hepatitis C Patients Treated with the Combined Pegylated Interferon-Ribavirin Therapy.
Topics: Adult; Antiviral Agents; Biomarkers; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Male; Middle Aged; Ribavirin; Thyroid Diseases; Thyroid Function Tests; Treatment Outcome; Viral Load; Young Adult | 2016 |
Frequency of thyroid disorders during interferon and ribavirin therapy in chronic hepatitis C infection.
Topics: Adult; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Ribavirin; Thyroid Diseases | 2008 |
Interferon-induced thyroid dysfunction in chronic hepatitis C.
Topics: Adult; Case-Control Studies; Chi-Square Distribution; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Sex Factors; Thyroid Diseases; Thyroid Function Tests; Western Australia | 2009 |
Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
Topics: Adult; Aged; Antiviral Agents; Autoimmunity; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Thyroid Diseases; Thyroid Function Tests; Thyroid Gland; Ultrasonography; Young Adult | 2009 |
Effects of combined interferon alpha and ribavirin therapy on thyroid functions in patients with chronic hepatitis C.
Topics: Adolescent; Adult; Antiviral Agents; Case-Control Studies; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin; Risk; Thyroid Diseases; Thyroid Function Tests; Treatment Outcome; Young Adult | 2009 |
Thyroid dysfunction in patients with chronic hepatitis C: virus- or therapy-related?
Topics: Adult; Antiviral Agents; Chi-Square Distribution; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Thyroid Diseases; Thyroid Function Tests | 2009 |
Interferon-induced thyroid dysfunction--not always transient.
Topics: Animals; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Thyroid Diseases; Time Factors | 2009 |
Thyroid dysfunction in a UK hepatitis C population treated with interferon-alpha and ribavirin combination therapy.
Topics: Adult; Age of Onset; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Retrospective Studies; Ribavirin; Thyroid Diseases; United Kingdom | 2010 |
The adjuvant role of thyroxine in the treatment of chronic hepatitis C infection.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Middle Aged; Ribavirin; Thyroid Diseases; Thyroxine | 2012 |
Thyroid dysfunction and long-term outcome during and after interferon-alpha therapy in patients with chronic hepatitis C.
Topics: Adult; Aged; Antiviral Agents; Case-Control Studies; Female; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Prevalence; Ribavirin; Sex Factors; Thyroid Diseases; Thyroid Function Tests; Time Factors; Young Adult | 2011 |
[Analysis of thyroid dysfunction and influencing factors in chronic hepatitis C patients treated with peg-IFNa-2a and ribavirin].
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Thyroid Diseases; Thyroid Gland; Treatment Outcome | 2012 |
Is the IFN-alpha-related thyroid autoimmunity an immunologically heterogeneous disease?
Topics: Antiviral Agents; Autoimmune Diseases; Autoimmunity; Drug Therapy, Combination; Genetic Predisposition to Disease; Hepatitis C, Chronic; Humans; Interferon-alpha; Ribavirin; Thyroid Diseases; Thyroid Gland | 2002 |
Incidence of thyroid dysfunction during interferon alfa-2b and ribavirin therapy in men with chronic hepatitis C: a prospective cohort study.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Ribavirin; Sex Factors; Thyroid Diseases; Treatment Outcome | 2004 |
Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: incidence, associated factors and prognosis.
Topics: Antiviral Agents; Autoantibodies; Case-Control Studies; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prognosis; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Thyroid Diseases; Thyrotropin; Thyroxine | 2006 |
The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.
Topics: Adult; Aged; Antiviral Agents; Autoantibodies; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin; Taiwan; Thyroid Diseases; Thyroid Gland | 2006 |
Thyrotoxic periodic paralysis induced by pegylated interferon alpha plus ribavirin for chronic hepatitis C.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Antiviral Agents; Carbimazole; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Propranolol; Quadriplegia; Recombinant Proteins; Ribavirin; Thyroid Diseases; Time Factors; Treatment Outcome | 2008 |
Interferon-associated thyroid dysfunction in anti-D-related chronic hepatitis C.
Topics: Antiviral Agents; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Genotype; Hepatitis C; Humans; Interferons; Retrospective Studies; Rho(D) Immune Globulin; Ribavirin; Thyroid Diseases | 1997 |